
Sign up to save your podcasts
Or


On this week's Companies and Markets Show editor John Hughman talks to Harriet Russell and Julia Faurschau about the ongoing struggles of the retail and travel industries, and how AstraZeneca has delivered a rare ray of sunshine in a difficult market.
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.
By Investors' Chronicle3.7
77 ratings
On this week's Companies and Markets Show editor John Hughman talks to Harriet Russell and Julia Faurschau about the ongoing struggles of the retail and travel industries, and how AstraZeneca has delivered a rare ray of sunshine in a difficult market.
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.

1,233 Listeners

52 Listeners

43 Listeners

77 Listeners

1,335 Listeners

590 Listeners

37 Listeners

88 Listeners

267 Listeners

49 Listeners

115 Listeners

17 Listeners

1,180 Listeners

840 Listeners

136 Listeners

1,027 Listeners

114 Listeners

12 Listeners

14 Listeners

4 Listeners

196 Listeners

50 Listeners

193 Listeners

12 Listeners

34 Listeners